Drug Type Diagnostic radiopharmaceuticals |
Synonyms [18F]UCB 2897 |
Target |
Mechanism α-synuclein modulators(Synuclein alpha modulators), Ionising radiation emitters |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple System Atrophy | Phase 1 | US | 31 Jan 2022 | |
Parkinson Disease | Phase 1 | US | 31 Jan 2022 |